Literature DB >> 22503078

Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids.

Helen Weaver1, Nilima Shukla, David Ellinsworth, Jamie Y Jeremy.   

Abstract

Recent interest has focused on superoxide and the upregulation of NADPH oxidase expression in the aetiology of vein graft failure. Implantation of saphenous vein grafts promotes upregulation of NADPH oxidase through a number of distinct interrelated mechanisms: (a) endothelial denudation, (b) factors released by adherent platelets, monocytes and neutrophils, (c) hypoxia and (d) altered prostacyclin (PGI(2)) and enhanced isoprostane formation. These, in turn, impact on neointima (NI) formation (vascular smooth muscle cell [VSMC] replication and migration) and metalloproteinase (MMP) expression, key events in vein graft thickening. NADPH oxidase in the aetiology of vein graft failure will be discussed in this review with particular reference to nitric oxide and eicosanoids and related drugs that inhibit its activity and expression.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22503078     DOI： 10.1016/j.coph.2012.01.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


  15 in total

1.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

2.  Short-term preoperative protein restriction attenuates vein graft disease via induction of cystathionine γ-lyase.

Authors:  Kaspar M Trocha; Peter Kip; Ming Tao; Michael R MacArthur; J Humberto Treviño-Villarreal; Alban Longchamp; Wendy Toussaint; Bart N Lambrecht; Margreet R de Vries; Paul H A Quax; James R Mitchell; C Keith Ozaki
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

Review 3.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

4.  Oxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences.

Authors:  Viviana Cavalca; Elena Tremoli; Benedetta Porro; Fabrizio Veglia; Veronika Myasoedova; Isabella Squellerio; Daniela Manzone; Marco Zanobini; Matteo Trezzi; Matteo Nicola Dario Di Minno; José Pablo Werba; Calogero Tedesco; Francesco Alamanni; Alessandro Parolari
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-07

Review 5.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 6.  Redox reactions of myoglobin.

Authors:  Mark P Richards
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

7.  Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Authors:  Michael J Osgood; Kyle M Hocking; Igor V Voskresensky; Fan Dong Li; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2013-07-30       Impact factor: 4.268

Review 8.  Endothelium-Derived Hyperpolarization and Coronary Vasodilation: Diverse and Integrated Roles of Epoxyeicosatrienoic Acids, Hydrogen Peroxide, and Gap Junctions.

Authors:  David C Ellinsworth; Shaun L Sandow; Nilima Shukla; Yanping Liu; Jamie Y Jeremy; David D Gutterman
Journal:  Microcirculation       Date:  2016-01       Impact factor: 2.628

Review 9.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

10.  Clinical Significance of Serum Kallistatin and ENOX1 Levels in Patients with Coronary Heart Disease.

Authors:  Rui Zhang; Zhenjun Ji; Junyan Cai; Yongjun Li; Genshan Ma
Journal:  Med Princ Pract       Date:  2020-07-24       Impact factor: 1.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.